Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Corneal neovascularization.

J H Chang1, E E Gabison, T Kato

  • 1Schepens Eye Research Institute and the Massachusetts Eye and Ear Infirmary, Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts 02114, USA.

Current Opinion in Ophthalmology
|August 17, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A prospective study for brain metastasis imaging screening in patients with advanced HER2-positive or triple-negative breast cancer.

ESMO open·2026
Same author

Socioeconomic disparities and osteoarthritis impact hormone therapy adherence in breast cancer.

Breast (Edinburgh, Scotland)·2025
Same author

Severe corneal manifestations of graft-versus-host disease: Experience of a tertiary referral center.

The ocular surface·2024
Same author

Outpatient vs. inpatient Descemet's membrane endothelial keratoplasty: Changing practice patterns in a COVID-19 environment.

Journal francais d'ophtalmologie·2022
Same author

MRI Features May Predict Molecular Features of Glioblastoma in <i>Isocitrate Dehydrogenase</i> Wild-Type Lower-Grade Gliomas.

AJNR. American journal of neuroradiology·2021
Same author

Changes in Bone Mineral Density After Kidney Transplantation.

Transplantation proceedings·2018
Same journal

Laser vision correction (LASIK, PRK, SMILE) with simultaneous accelerated corneal crosslinking.

Current opinion in ophthalmology·2026
Same journal

Traumatic macular hole: observe, operate, or other options.

Current opinion in ophthalmology·2026
Same journal

The evolving role of artificial intelligence in ophthalmology: basic science, translation, and clinical integration.

Current opinion in ophthalmology·2026
Same journal

Editorial: reducing risk for refractive surgery.

Current opinion in ophthalmology·2026
Same journal

Updates on Refractive Surgery: Benefits, Risks, and Costs of Modern Treatment Options.

Current opinion in ophthalmology·2026
Same journal

Corneal Allogeneic Intrastromal Ring Segments for keratoconus - recent evidence and the move to customized and custom shaped CAIRS.

Current opinion in ophthalmology·2026
See all related articles

Corneal neovascularization (NV), a cause of vision loss, occurs when the balance of angiogenic factors is disrupted. Treatments targeting this imbalance show promise in animal models for inhibiting NV.

Area of Science:

  • Ophthalmology
  • Angiogenesis Research
  • Corneal Disease

Background:

  • Corneal neovascularization (NV) is a significant cause of vision impairment, often linked to ocular surface inflammation or infection.
  • A delicate balance between pro-angiogenic factors (e.g., FGF, VEGF) and anti-angiogenic molecules (e.g., angiostatin, endostatin) normally maintains the cornea's avascular state.
  • Disruptions in this balance, favoring angiogenesis, are implicated in various corneal disorders, including inflammatory, infectious, degenerative, and traumatic conditions.

Purpose of the Study:

  • To explore the pathogenesis of corneal neovascularization (NV).
  • To review the role of angiogenic and anti-angiogenic factors in corneal NV.
  • To summarize current and emerging treatments for corneal NV.

Main Methods:

Related Experiment Videos

  • Review of existing literature on corneal neovascularization (NV) and angiogenesis.
  • Analysis of the role of growth factors, anti-angiogenic molecules, and matrix metalloproteinases in corneal NV.
  • Evaluation of the efficacy of various medical and surgical treatments in preclinical models.

Main Results:

  • Corneal NV results from an imbalance favoring angiogenic factors over anti-angiogenic molecules.
  • Matrix metalloproteinases and proteolytic enzymes may contribute to the pathogenesis of corneal NV.
  • Several therapeutic strategies, including angiostatic steroids, NSAIDs, laser photocoagulation, and photodynamic therapy, have demonstrated efficacy in inhibiting corneal NV in animal models.

Conclusions:

  • Corneal neovascularization (NV) is a complex process driven by an angiogenic imbalance.
  • Targeting angiogenic pathways offers potential therapeutic strategies for sight-threatening corneal NV.
  • Further research and clinical translation are needed to restore corneal avascularity and preserve vision.